News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ)'s Weak Pharma Revenue Could Spell Doom For Rest Of Sector



4/19/2017 5:57:19 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Johnson & Johnson ( JNJ) shares closed down about 3% after the company reported first quarter revenue that missed analysts' expectations due to lighter than expected pharmaceutical sales.

The company reported first quarter earnings of $1.83 per share on revenue of $17.7 billion vs. Wall Street expectations of earnings of $1.77 per share on revenue of $18.04 billion. The company said U.S. pharmaceutical sales fell about 3% quarter-over-quarter to about $4.87 billion.


Read at The Street.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES